NGNE

Neurogene Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 4/10
  • Value↑ 5/10
Neurogene sales and earnings growth
NGNE Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 87.51%
  • FCF Y/Y↓ -10.60%
Neurogene gross and profit margin trends
NGNE Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -69.79%
Neurogene net debt vs free cash flow
NGNE Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -14187.3

Neurogene stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗